Nakayama Takeo
Department of Health Informatics, School of Public Health, Kyoto University.
Department of Ethics Support, Kyoto University Hospital.
Rinsho Ketsueki. 2024;65(9):1234-1238. doi: 10.11406/rinketsu.65.1234.
Evidence-based medicine (EBM) is "decision-making for better patient care that integrates current evidence, and clinical expertise with patients' preferences, values and circumstances." It is important to distinguish research evidence from EBM, which is comprehensive decision-making that takes into account the diversity and individuality of clinical situations while respecting evidence as a general theory. Clinical practice guidelines are "a document that evaluates the total body of evidence through systematic review and presents recommendations that are considered optimal, taking into account the balance of benefits and harms, in order to support decision-making on important health-related issues by healthcare users and providers," and is useful in the practice of EBM. Shared decision making (SDM), which has been attracting attention in recent years, is "a process in which the patient and the health care provider, through dialogue, decide on a treatment plan that is acceptable to the patient, based on the patient's own preferences and values, research evidence, and clinical expertise" and must be understood in relation to the above definition of EBM and from the perspective of clinical ethics.
循证医学(EBM)是“为改善患者护理而进行的决策,它将当前证据、临床专业知识与患者的偏好、价值观和具体情况相结合”。重要的是要区分研究证据与循证医学,循证医学是一种全面的决策,在尊重证据这一普遍理论的同时,考虑到临床情况的多样性和个体性。临床实践指南是“一份通过系统评价来评估全部证据,并在考虑利弊平衡的基础上提出被认为是最佳的建议,以支持医疗保健使用者和提供者就重要的健康相关问题进行决策的文件”,并且在循证医学实践中很有用。近年来备受关注的共同决策(SDM)是“患者和医疗保健提供者通过对话,根据患者自身的偏好和价值观、研究证据以及临床专业知识,决定一个患者可接受的治疗方案的过程”,并且必须结合上述循证医学的定义并从临床伦理学的角度来理解。